Cytosorbents Corporation (CTSO)
USD 0.99
(-1.0%)
USD 0.99
(-1.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -28.81 Million USD | 1.88% |
| 2022 | -30 Million USD | -44.16% |
| 2021 | -22.01 Million USD | -94.47% |
| 2020 | -9.7 Million USD | 45.35% |
| 2019 | -18.74 Million USD | -24.88% |
| 2018 | -15.97 Million USD | -37.15% |
| 2017 | -8.17 Million USD | -2.61% |
| 2016 | -11.86 Million USD | -7.66% |
| 2015 | -9.19 Million USD | -37.78% |
| 2014 | -6.82 Million USD | -56.58% |
| 2013 | -4.64 Million USD | -35.29% |
| 2012 | -3.43 Million USD | 21.86% |
| 2011 | -4.39 Million USD | -246.03% |
| 2010 | -2.8 Million USD | -2.71% |
| 2009 | -2.97 Million USD | 198.56% |
| 2008 | -3.14 Million USD | -24.39% |
| 2007 | -3.16 Million USD | -45.07% |
| 2006 | -1.74 Million USD | -2386.28% |
| 2005 | -70 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.41 Million USD | 46.64% |
| 2024 Q2 | -2.78 Million USD | 37.43% |
| 2023 Q4 | -8.36 Million USD | -13.86% |
| 2023 Q2 | -6.51 Million USD | 23.81% |
| 2023 Q1 | -8.55 Million USD | 19.28% |
| 2023 Q3 | -7.35 Million USD | -12.79% |
| 2023 FY | - USD | 1.88% |
| 2022 Q3 | -5.5 Million USD | 0.57% |
| 2022 Q4 | -10.59 Million USD | -92.32% |
| 2022 Q2 | -5.54 Million USD | 11.99% |
| 2022 FY | - USD | -44.16% |
| 2022 Q1 | -6.29 Million USD | 30.57% |
| 2021 Q4 | -9.06 Million USD | -118.2% |
| 2021 FY | - USD | -94.47% |
| 2021 Q1 | -2.69 Million USD | -9.21% |
| 2021 Q2 | -5.03 Million USD | -86.77% |
| 2021 Q3 | -4.15 Million USD | 17.46% |
| 2020 Q1 | -2.47 Million USD | 52.91% |
| 2020 Q2 | -3.13 Million USD | -26.63% |
| 2020 Q4 | -2.46 Million USD | -25.94% |
| 2020 Q3 | -1.96 Million USD | 37.56% |
| 2020 FY | - USD | 45.35% |
| 2019 Q1 | -3.75 Million USD | 31.15% |
| 2019 FY | - USD | -24.88% |
| 2019 Q2 | -3.49 Million USD | 6.95% |
| 2019 Q3 | -5.62 Million USD | -61.1% |
| 2019 Q4 | -5.26 Million USD | 6.45% |
| 2018 Q1 | -3.04 Million USD | 41.48% |
| 2018 Q2 | -4.12 Million USD | -35.55% |
| 2018 FY | - USD | -37.15% |
| 2018 Q3 | -2.57 Million USD | 37.69% |
| 2018 Q4 | -5.45 Million USD | -112.01% |
| 2017 Q3 | -2.09 Million USD | 42.38% |
| 2017 FY | - USD | -2.61% |
| 2017 Q1 | -1.79 Million USD | 59.91% |
| 2017 Q2 | -3.62 Million USD | -102.25% |
| 2017 Q4 | -5.2 Million USD | -148.82% |
| 2016 Q2 | -2.33 Million USD | -1.01% |
| 2016 Q1 | -2.3 Million USD | 22.15% |
| 2016 FY | - USD | -7.66% |
| 2016 Q4 | -4.47 Million USD | -165.91% |
| 2016 Q3 | -1.68 Million USD | 27.79% |
| 2015 Q4 | -2.96 Million USD | -109.35% |
| 2015 FY | - USD | -37.78% |
| 2015 Q3 | -1.41 Million USD | 75.85% |
| 2015 Q2 | -5.86 Million USD | -758.93% |
| 2015 Q1 | -682.57 Thousand USD | 6.31% |
| 2014 Q3 | -1.89 Million USD | -86.92% |
| 2014 Q2 | -1.01 Million USD | 30.08% |
| 2014 Q1 | -1.45 Million USD | -46.91% |
| 2014 FY | - USD | -56.58% |
| 2014 Q4 | -728.55 Thousand USD | 61.58% |
| 2013 Q4 | -987.53 Thousand USD | -14.32% |
| 2013 Q1 | -1.4 Million USD | -78.14% |
| 2013 Q2 | -1.38 Million USD | 1.33% |
| 2013 Q3 | -863.85 Thousand USD | 37.83% |
| 2013 FY | - USD | -35.29% |
| 2012 FY | - USD | 21.86% |
| 2012 Q1 | -1.05 Million USD | -9.1% |
| 2012 Q3 | -590.47 Thousand USD | 40.88% |
| 2012 Q2 | -998.79 Thousand USD | 5.46% |
| 2012 Q4 | -790.44 Thousand USD | -33.87% |
| 2011 Q4 | -968.43 Thousand USD | 19.98% |
| 2011 Q1 | -1.12 Million USD | -120.68% |
| 2011 Q2 | -1.09 Million USD | 2.65% |
| 2011 Q3 | -1.21 Million USD | -10.87% |
| 2011 FY | - USD | -246.03% |
| 2010 Q2 | -669.95 Thousand USD | 30.46% |
| 2010 Q4 | 5.42 Million USD | 798.38% |
| 2010 Q3 | -776.23 Thousand USD | -15.86% |
| 2010 FY | - USD | -2.71% |
| 2010 Q1 | -963.35 Thousand USD | -117.46% |
| 2009 Q4 | 5.51 Million USD | 766.59% |
| 2009 Q2 | -840.6 Thousand USD | -11.63% |
| 2009 Q1 | -753 Thousand USD | 15.4% |
| 2009 FY | - USD | 198.56% |
| 2009 Q3 | -827.58 Thousand USD | 1.55% |
| 2008 Q2 | 837.22 Thousand USD | 234.89% |
| 2008 FY | - USD | -24.39% |
| 2008 Q1 | -620.65 Thousand USD | -11.29% |
| 2008 Q4 | -890.04 Thousand USD | -5.4% |
| 2008 Q3 | -844.4 Thousand USD | -200.86% |
| 2007 Q2 | -455.11 Thousand USD | 42.49% |
| 2007 FY | - USD | -45.07% |
| 2007 Q4 | -557.7 Thousand USD | 22.6% |
| 2007 Q3 | -720.57 Thousand USD | -58.33% |
| 2007 Q1 | -791.3 Thousand USD | 5.7% |
| 2006 Q4 | -839.14 Thousand USD | -38.78% |
| 2006 Q1 | -8645.00 USD | -28.42% |
| 2006 Q3 | -604.66 Thousand USD | -3.99% |
| 2006 FY | - USD | -2386.28% |
| 2006 Q2 | -581.44 Thousand USD | -6625.81% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | -6732.00 USD | 20.45% |
| 2005 Q3 | -8463.00 USD | 15.37% |
| 2005 Q2 | -10 Thousand USD | 0.0% |
| 2005 Q1 | -10 Thousand USD | 60.02% |
| 2004 Q4 | -25.01 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -113.619% |
| Cerus Corporation | -26.53 Million USD | -8.573% |
| OrthoPediatrics Corp. | -8.38 Million USD | -243.763% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -174.533% |
| Talis Biomedical Corporation | -66.04 Million USD | 56.377% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -72.779% |
| Inogen, Inc. | -45.67 Million USD | 36.928% |
| Spectral AI, Inc. | -12.26 Million USD | -134.96% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 39.591% |
| CVRx, Inc. | -38.73 Million USD | 25.613% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -716.633% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -137.968% |
| Orthofix Medical Inc. | -86.98 Million USD | 66.878% |
| Venus Concept Inc. | -26.11 Million USD | -10.331% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 42.113% |
| Bioventus Inc. | -23.07 Million USD | -24.884% |
| BrainsWay Ltd. | -2.31 Million USD | -1146.682% |
| Envoy Medical, Inc. | -18.23 Million USD | -57.971% |
| electroCore, Inc. | -17.76 Million USD | -62.223% |
| IceCure Medical Ltd | -15.25 Million USD | -88.886% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 42.09% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -70.926% |
| MaxCyte, Inc. | -44.12 Million USD | 34.711% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -145.074% |
| Nexalin Technology, Inc. | -5.69 Million USD | -406.16% |
| PAVmed Inc | -75.74 Million USD | 61.962% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 46.406% |
| RxSight, Inc. | -41.03 Million USD | 29.793% |
| Sight Sciences, Inc. | -49.41 Million USD | 41.696% |
| SI-BONE, Inc. | -34.44 Million USD | 16.359% |
| TELA Bio, Inc. | -40.63 Million USD | 29.095% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 50.58% |
| Treace Medical Concepts, Inc. | -39 Million USD | 26.141% |
| LivaNova PLC | 39.01 Million USD | 173.844% |
| 908 Devices Inc. | -34.02 Million USD | 15.325% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 73.949% |
| Nemaura Medical Inc. | -7.28 Million USD | -295.37% |
| NeuroPace, Inc. | -22.83 Million USD | -26.175% |
| LENSAR, Inc. | -8.71 Million USD | -230.627% |
| Apyx Medical Corporation | -18.11 Million USD | -59.07% |
| Cutera, Inc. | -136.56 Million USD | 78.903% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -752.391% |
| BioSig Technologies, Inc. | -28.15 Million USD | -2.344% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1245.104% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -37.266% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 107.511% |
| Axonics, Inc. | 7.77 Million USD | 470.557% |
| Outset Medical, Inc. | -153.78 Million USD | 81.266% |
| IRIDEX Corporation | -7.44 Million USD | -286.826% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 70.63% |
| IRadimed Corporation | 20.8 Million USD | 238.509% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -257.366% |
| INVO Bioscience, Inc. | -6.88 Million USD | -318.76% |
| Telesis Bio, Inc. | -40.49 Million USD | 28.85% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 178.553% |
| Varex Imaging Corporation | 67.2 Million USD | 142.873% |
| Quipt Home Medical Corp. | 44.07 Million USD | 165.374% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -165.049% |
| Pulmonx Corporation | -55.09 Million USD | 47.704% |
| Dynatronics Corporation | -976 Thousand USD | -2851.904% |
| Modular Medical, Inc. | -17.1 Million USD | -68.455% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -98.901% |
| Semler Scientific, Inc. | 23.58 Million USD | 222.137% |
| InMode Ltd. | 196.28 Million USD | 114.678% |
| Bruker Corporation | 599 Million USD | 104.81% |
| DexCom, Inc. | 916.7 Million USD | 103.143% |
| Align Technology, Inc. | 799.03 Million USD | 103.606% |
| Viveve Medical, Inc. | -20.61 Million USD | -39.743% |
| ZimVie Inc. | 91.07 Million USD | 131.635% |
| Movano Inc. | -29.12 Million USD | 1.079% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -553.603% |
| Nexalin Technology, Inc. | -5.69 Million USD | -406.16% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -716.633% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 85.199% |
| Profound Medical Corp. | -27.12 Million USD | -6.221% |
| Insulet Corporation | 323.6 Million USD | 108.903% |
| enVVeno Medical Corporation | -25.01 Million USD | -15.16% |
| Surmodics, Inc. | 1.18 Million USD | 2525.153% |
| iCAD, Inc. | -6.56 Million USD | -338.855% |
| Nuwellis, Inc. | -16.35 Million USD | -76.148% |
| Biotricity, Inc. | -8.82 Million USD | -226.347% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 70.256% |
| Aethlon Medical, Inc. | -11.84 Million USD | -143.147% |
| InspireMD, Inc. | -20.91 Million USD | -37.778% |
| PAVmed Inc. | -75.74 Million USD | 61.962% |
| BIOLASE, Inc. | -15.13 Million USD | -90.309% |
| Beyond Air, Inc. | -59.03 Million USD | 51.194% |
| FONAR Corporation | 28.25 Million USD | 201.98% |
| AxoGen, Inc. | -13.32 Million USD | -116.168% |
| Vivani Medical, Inc. | -26.6 Million USD | -8.279% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 217.399% |
| Inari Medical, Inc. | 7.11 Million USD | 505.045% |
| UFP Technologies, Inc. | 72.74 Million USD | 139.606% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -750.934% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -368.012% |
| Tenon Medical, Inc. | -15.52 Million USD | -85.541% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -88.725% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 30.536% |
| AdaptHealth Corp. | -171.09 Million USD | 83.161% |
| Sintx Technologies, Inc. | -6.6 Million USD | -336.528% |
| NanoVibronix, Inc. | -3.43 Million USD | -738.743% |
| Quanterix Corporation | -38.08 Million USD | 24.357% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -165.049% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 96136.057% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 89.61% |
| TransMedics Group, Inc. | -7.6 Million USD | -278.94% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -32.372% |
| NeuroMetrix, Inc. | -7.09 Million USD | -306.026% |
| Hyperfine, Inc. | -47.06 Million USD | 38.78% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 50.588% |
| Biomerica, Inc. | -5.99 Million USD | -380.741% |
| Bone Biologics Corporation | 479.57 Thousand USD | 6107.61% |
| AVITA Medical, Inc. | -39.56 Million USD | 27.186% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -214.085% |
| Silk Road Medical, Inc | -45.08 Million USD | 36.09% |